OBMP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products...

Stats
Dagens volum	58 992.00
Gjennomsnittsvolum	8 379.00
Markedsverdi	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2020-09-24	Chilcott, Iii Thomas E.	Buy	0
2020-06-05	Ruxin Michael I	Buy	0
2020-05-07	Head Jonathan Frederick	Buy	166 667	Shares of Common Stock
2019-04-24	Holcomb Robert Neal	Buy	3 000 000	Employee Stock Option (right to buy)
2019-04-24	Hoverman Daniel S.	Buy	3 000 000	Employee Stock Option (right to buy)

INSIDER POWER
0.00
Last 25 transactions
Buy: 69 901 401 \| Sell: 14 397 245

Theralink Technologies, Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Theralink Technologies, Økonomi

Annual	2021
Omsetning:	$505 604
Bruttogevinst:	$388 148 (76.77 %)
EPS:	$-0.00124

FY	2021
Omsetning:	$505 604
Bruttogevinst:	$388 148 (76.77 %)
EPS:	$-0.00124

FY	2020
Omsetning:	$181 229
Bruttogevinst:	$128 642 (70.98 %)
EPS:	$-0.0374

FY	2019
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-19.00

Financial Reports:

No articles found.

Theralink Technologies,

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.